STEVEN GROSSMAN 12/20/24 STEVEN GROSSMAN 12/20/24 Continuing Resolution Scramble Read More Analysis and Commentary STEVEN GROSSMAN 12/20/24 Analysis and Commentary STEVEN GROSSMAN 12/20/24 Steven’s Final Thoughts and Where to Find Him in the Future Read More Advocacy at a Glance STEVEN GROSSMAN 12/13/24 Advocacy at a Glance STEVEN GROSSMAN 12/13/24 Continuing Resolution Negotiations Ongoing - No Shutdown Expected Read More Analysis and Commentary STEVEN GROSSMAN 12/13/24 Analysis and Commentary STEVEN GROSSMAN 12/13/24 Steven’s Remarks on Accepting the RUF Award for His Advocacy and Policy Leadership Read More Advocacy at a Glance STEVEN GROSSMAN 12/6/24 Advocacy at a Glance STEVEN GROSSMAN 12/6/24 Finishing Out 2024: FY 25 Continuing Resolution Almost a Certainty Read More Analysis and Commentary STEVEN GROSSMAN 12/6/24 Analysis and Commentary STEVEN GROSSMAN 12/6/24 Republican Control in 2025 Will Prioritize Large Cuts in Federal Spending Read More Advocacy at a Glance STEVEN GROSSMAN 11/22/24 Advocacy at a Glance STEVEN GROSSMAN 11/22/24 Speaker Johnson Predicts Continuing Resolution through March Read More Analysis and Commentary STEVEN GROSSMAN 11/22/24 Analysis and Commentary STEVEN GROSSMAN 11/22/24 Steven’s Traditional Thanksgiving Message to the FDA Stakeholder Community Read More Analysis and Commentary STEVEN GROSSMAN 11/22/24 Analysis and Commentary STEVEN GROSSMAN 11/22/24 FDA 101: What Every American Should Know (and Be Grateful For) Read More Advocacy at a Glance STEVEN GROSSMAN 11/15/24 Advocacy at a Glance STEVEN GROSSMAN 11/15/24 TBD: Final Action on FY 25 Funding In December or a CR Until Next Year? Read More Analysis and Commentary STEVEN GROSSMAN 11/15/24 Analysis and Commentary STEVEN GROSSMAN 11/15/24 FDA Impacted by the Larger Transition: Some More Q&A Read More Advocacy at a Glance STEVEN GROSSMAN 11/8/24 Advocacy at a Glance STEVEN GROSSMAN 11/8/24 Post-election Media Inquiries Read More Analysis and Commentary STEVEN GROSSMAN 11/8/24 Analysis and Commentary STEVEN GROSSMAN 11/8/24 Presidential Transition Has Arrived at FDA: Some Q&A Read More Advocacy at a Glance STEVEN GROSSMAN 11/1/24 Advocacy at a Glance STEVEN GROSSMAN 11/1/24 A Rough Couple of Months for FDA and Other Government Agencies Read More Analysis and Commentary STEVEN GROSSMAN 11/1/24 Analysis and Commentary STEVEN GROSSMAN 11/1/24 Presidential Transition: Coming Soon to the FDA Read More Advocacy at a Glance STEVEN GROSSMAN 10/18/24 Advocacy at a Glance STEVEN GROSSMAN 10/18/24 No Appropriations Action Expected Until After the Election Read More Analysis and Commentary STEVEN GROSSMAN 10/18/24 Analysis and Commentary STEVEN GROSSMAN 10/18/24 Steven Is Moving On to New FDA Challenges Read More Advocacy at a Glance STEVEN GROSSMAN 10/4/24 Advocacy at a Glance STEVEN GROSSMAN 10/4/24 Congress in Recess; Much to Do When They Return November 12 Read More Analysis and Commentary STEVEN GROSSMAN 10/4/24 Analysis and Commentary STEVEN GROSSMAN 10/4/24 We Got the FY 25 CR Story Right, What’s Next? Part 2 Read More Advocacy at a Glance STEVEN GROSSMAN 9/27/24 Advocacy at a Glance STEVEN GROSSMAN 9/27/24 House and Senate Approve Continuing Resolution Through December 20 Read More Older Posts
Analysis and Commentary STEVEN GROSSMAN 12/20/24 Analysis and Commentary STEVEN GROSSMAN 12/20/24 Steven’s Final Thoughts and Where to Find Him in the Future Read More
Advocacy at a Glance STEVEN GROSSMAN 12/13/24 Advocacy at a Glance STEVEN GROSSMAN 12/13/24 Continuing Resolution Negotiations Ongoing - No Shutdown Expected Read More
Analysis and Commentary STEVEN GROSSMAN 12/13/24 Analysis and Commentary STEVEN GROSSMAN 12/13/24 Steven’s Remarks on Accepting the RUF Award for His Advocacy and Policy Leadership Read More
Advocacy at a Glance STEVEN GROSSMAN 12/6/24 Advocacy at a Glance STEVEN GROSSMAN 12/6/24 Finishing Out 2024: FY 25 Continuing Resolution Almost a Certainty Read More
Analysis and Commentary STEVEN GROSSMAN 12/6/24 Analysis and Commentary STEVEN GROSSMAN 12/6/24 Republican Control in 2025 Will Prioritize Large Cuts in Federal Spending Read More
Advocacy at a Glance STEVEN GROSSMAN 11/22/24 Advocacy at a Glance STEVEN GROSSMAN 11/22/24 Speaker Johnson Predicts Continuing Resolution through March Read More
Analysis and Commentary STEVEN GROSSMAN 11/22/24 Analysis and Commentary STEVEN GROSSMAN 11/22/24 Steven’s Traditional Thanksgiving Message to the FDA Stakeholder Community Read More
Analysis and Commentary STEVEN GROSSMAN 11/22/24 Analysis and Commentary STEVEN GROSSMAN 11/22/24 FDA 101: What Every American Should Know (and Be Grateful For) Read More
Advocacy at a Glance STEVEN GROSSMAN 11/15/24 Advocacy at a Glance STEVEN GROSSMAN 11/15/24 TBD: Final Action on FY 25 Funding In December or a CR Until Next Year? Read More
Analysis and Commentary STEVEN GROSSMAN 11/15/24 Analysis and Commentary STEVEN GROSSMAN 11/15/24 FDA Impacted by the Larger Transition: Some More Q&A Read More
Advocacy at a Glance STEVEN GROSSMAN 11/8/24 Advocacy at a Glance STEVEN GROSSMAN 11/8/24 Post-election Media Inquiries Read More
Analysis and Commentary STEVEN GROSSMAN 11/8/24 Analysis and Commentary STEVEN GROSSMAN 11/8/24 Presidential Transition Has Arrived at FDA: Some Q&A Read More
Advocacy at a Glance STEVEN GROSSMAN 11/1/24 Advocacy at a Glance STEVEN GROSSMAN 11/1/24 A Rough Couple of Months for FDA and Other Government Agencies Read More
Analysis and Commentary STEVEN GROSSMAN 11/1/24 Analysis and Commentary STEVEN GROSSMAN 11/1/24 Presidential Transition: Coming Soon to the FDA Read More
Advocacy at a Glance STEVEN GROSSMAN 10/18/24 Advocacy at a Glance STEVEN GROSSMAN 10/18/24 No Appropriations Action Expected Until After the Election Read More
Analysis and Commentary STEVEN GROSSMAN 10/18/24 Analysis and Commentary STEVEN GROSSMAN 10/18/24 Steven Is Moving On to New FDA Challenges Read More
Advocacy at a Glance STEVEN GROSSMAN 10/4/24 Advocacy at a Glance STEVEN GROSSMAN 10/4/24 Congress in Recess; Much to Do When They Return November 12 Read More
Analysis and Commentary STEVEN GROSSMAN 10/4/24 Analysis and Commentary STEVEN GROSSMAN 10/4/24 We Got the FY 25 CR Story Right, What’s Next? Part 2 Read More
Advocacy at a Glance STEVEN GROSSMAN 9/27/24 Advocacy at a Glance STEVEN GROSSMAN 9/27/24 House and Senate Approve Continuing Resolution Through December 20 Read More
